Key facts
- Ultrahuman’s last known valuation is $575.0M.
- It has raised $109.9M.
- Notable investors include Blume Venture Advisors, Kunal Shah, Rainmatter Capital, Nexus Venture Partners, Alpha Wave Global — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Ultrahuman
- ·The full record, as it builds
Funding rounds
No funding rounds for Ultrahuman are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ultrahuman
Developer of metabolic health and fitness monitoring devices intended to help users transform themselves. The company's devices monitor environmental markers that affect users' health every day and allow them to track their meditation, body workouts, and bedtime, enabling users to meditate, work, and optimize their sleep efficiently.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2019
- Employees
- 125
- Website
- ultrahuman.com/
- Ownership
- Privately Held (backing)
Ultrahuman doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ultrahuman shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ultrahuman in its N-PORT filings yet. We sweep new filings monthly.